Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Media entities : Novartis ag save search
Novartis data highlight efficacy of Piqray® in HR+/HER2- metastatic breast cancer with a PIK3CA driver mutation immediately post-CDK4/6i
Published: 2021-12-10 (Crawled : 13:00) - globenewswire.com
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: -0.31%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
piqray novartis media cancer breast cancer her2- her2 metastatic breast cancer
Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Published: 2021-09-19 (Crawled : 16:20) - globenewswire.com
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
| Email alert
Add to watchlist
media cancer breast cancer her2+ her2- her2
Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
Published: 2021-06-03 (Crawled : 22:00) - globenewswire.com
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: 0.55%
H: 0.41%
C: 0.0%
media therapy
Novartis Kisqali® reports longest median overall survival in postmenopausal HR+/HER2- metastatic breast cancer patients
Published: 2021-06-02 (Crawled : 14:00) - biospace.com/
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: 0.85%
H: 0.37%
C: 0.02%
media cancer breast cancer her2+ her2- her2 metastatic breast cancer
Sandoz in-licenses brand and authorized generic of respiratory medicine Proventil® HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, with immediate generic availability in US
Published: 2021-03-16 (Crawled : 20:00) - prnewswire.com
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -1.0%
H: 0.82%
C: 0.58%
media respiratory drug license drug delivery liver authorized
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.